
NewLeaf Symbiotics
NewLeaf Symbiotics: An agri-biotech firm innovating plant health and yield with beneficial bacteria.

NewLeaf Symbiotics: An agri-biotech firm innovating plant health and yield with beneficial bacteria.
NewLeaf Symbiotics, founded with a mission to revolutionize agriculture through biotechnology, focuses on enhancing plant health and crop yield using beneficial bacteria known as PPFMs (Pink Pigmented Facultative Methylotrophs). The company develops and commercializes these bacteria, which are naturally occurring and promote early growth and increased yield in crops. NewLeaf's products, including the EPA-registered bioinsecticide TS201, are marketed across the United States and aim to integrate seamlessly into existing pest management systems.
Notable figures affiliated with NewLeaf Symbiotics include experienced agricultural scientists and biotech industry veterans. The company has secured investments from prominent venture capital firms, enabling significant research and development advancements. Key achievements include the successful registration of their bioinsecticide with the EPA and the widespread adoption of their products by farmers. NewLeaf Symbiotics has made a substantial impact on sustainable agriculture by providing innovative solutions that enhance crop productivity and resilience.
Companies similar to NewLeaf Symbiotics include Adaptive Symbiotic Technologies, Lytos Technologies, Intrinsyx Bio and Organicin Scientific.
NewLeaf Symbiotics was founded in 2012.
NewLeaf Symbiotics' headquarters is located in St. Louis, MO, US.
NewLeaf Symbiotics' most recent funding round was for $47M (USD) in December 2023.
As of Dec 19, 2023, NewLeaf Symbiotics has disclosed funding of $134.6M (USD). Undisclosed round amounts are excluded.
NewLeaf Symbiotics has 45 employees as of Feb 5, 2024.

Organicin Scientific